Viridian Therapeutics Inc (VRDN NASDAQ) stock market data APIs
$29.0044
1.32(4.6%)
as of February 5, 2026
Try our APIs with
free plan!
Viridian Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Prev. Close
29.0044
Open
30.3208
High
30.8207
Low
28.814
52 wk Range
9.9-34.29
Market Cap
2 899 M
Shares Outstanding
95 368 K
Revenue
70 789 K
EPS
-0.34
Beta
0.977
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Viridian Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Viridian Therapeutics Inc data using free add-ons & libraries
Get Viridian Therapeutics Inc Fundamental Data
Viridian Therapeutics Inc Fundamental data includes:
- Net Revenue: 70 789 K
- EBITDA: -324 155 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.9532
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Viridian Therapeutics Inc News
New
Exploring US High Growth Tech Stocks In February 2026
As the United States stock market kicks off February with a rise in major indices like the Dow Jones and S&P 500, investors are keeping a close watch on economic indicators and geopolitical developmen...
Thyroid Eye Disease Market - A Global and Regional Analysis: Focus on Country and Region, 2025-2035
Company Logo The global thyroid eye disease (TED) market is experiencing growth due to innovative treatment options, enhanced diagnostics, and increased awareness. TED, linked to hyperthyroidism, cau...
Exploring High Growth Tech Stocks In The US Market
The U.S. stock market has recently experienced a period of volatility, with major indexes like the S&P 500 and Dow Jones Industrial Average posting consecutive weekly losses, while safe-haven assets s...
Exploring US High Growth Tech Stocks In December 2025
As the U.S. stock market continues to reach new heights with the S&P 500 and Dow Jones Industrial Average setting all-time records, investor attention remains sharply focused on high growth sectors su...
Get Viridian Therapeutics Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
